SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
200 hedge funds and large institutions have $1.23B invested in Sage Therapeutics in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 78 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3.25% less ownership
Funds ownership: 98.17% → 94.92% (-3.3%)
42% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 78
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
200
Holding in Top 10
–
Calls
$14.9M
Puts
$7.46M
Top Buyers
| 1 | +$29M | |
| 2 | +$19M | |
| 3 | +$9.69M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.62M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$6.97M |
Top Sellers
| 1 | -$48M | |
| 2 | -$22.5M | |
| 3 | -$11.1M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$10.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$9.97M |